Transcription factor NF-κB regulates inducible CD83 gene expression in activated T lymphocytes

被引:45
作者
McKinsey, TA
Chu, ZL
Tedder, TF
Ballard, DW
机构
[1] Vanderbilt Univ, Dept Microbiol & Immunol, Sch Med, Nashville, TN 37232 USA
[2] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA
关键词
transcription factor NF-kappa B; CD83 gene expression; T lymphocytes;
D O I
10.1016/S0161-5890(00)00099-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The immunoglobulin superfamily member CD83 is expressed on the surface of mature dendritic cells that present processed antigens to T lymphocytes. In addition, T cells acquire CD83 expression following mitogenic stimulation in vitro. Here we report two lines of evidence demonstrating that this inducible lymphocyte response is genetically programmed by transcription factor NF-kappaB and contingent upon proteolytic breakdown of its cytoplasmic inhibitor I kappaB alpha. First, signal-dependent induction of CD83 mRNA expression is blocked in both transformed and primary T cells harboring a degradation-resistant mutant of I kappaB alpha that constitutively represses NF-kappaB. Second, as revealed in gel retardation assays, the I kappaB alpha constitutive repressor prevents the inducible interaction of NF-kappaB with consensus recognition sites identified in the CD83 promoter. Given that I kappaB alpha is functionally coupled to the T-cell antigen receptor, these findings suggest that the downstream transcription unit for CD83 is triggered by NF-kappaB during an adaptive immune response. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:783 / 788
页数:6
相关论文
共 25 条
[1]   THE V-REL ONCOGENE ENCODES A KAPPA-B ENHANCER BINDING-PROTEIN THAT INHIBITS NF-KAPPA-B FUNCTION [J].
BALLARD, DW ;
WALKER, WH ;
DOERRE, S ;
SISTA, P ;
MOLITOR, JA ;
DIXON, EP ;
PEFFER, NJ ;
HANNINK, M ;
GREENE, WC .
CELL, 1990, 63 (04) :803-814
[2]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[3]   Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappa B [J].
Boothby, MR ;
Mora, AL ;
Scherer, DC ;
Brockman, JA ;
Ballard, DW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (11) :1897-1907
[4]  
BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809
[5]   CENTRAL OF I-KAPPA-B-ALPHA PROTEOLYSIS BY SITE-SPECIFIC, SIGNAL-INDUCED PHOSPHORYLATION [J].
BROWN, K ;
GERSTBERGER, S ;
CARLSON, L ;
FRANZOSO, G ;
SIEBENLIST, U .
SCIENCE, 1995, 267 (5203) :1485-1488
[6]   Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappa B control [J].
Chu, ZL ;
McKinsey, TA ;
Liu, L ;
Gentry, JJ ;
Malim, MH ;
Ballard, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (19) :10057-10062
[7]   CONTINGENT GENETIC REGULATORY EVENTS IN LYMPHOCYTE-T ACTIVATION [J].
CRABTREE, GR .
SCIENCE, 1989, 243 (4889) :355-361
[8]   Regulation of inducible gene expression by the transcription factor NF-κB [J].
Ghosh, S .
IMMUNOLOGIC RESEARCH, 1999, 19 (2-3) :183-190
[9]  
HUNKAPILLER T, 1989, ADV IMMUNOL, V44, P1
[10]   The beginning of the end:: IκB kinase (IKK) and NF-κB activation [J].
Karin, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (39) :27339-27342